Literature DB >> 9481038

Structural aspects of monoamine oxidase and its reversible inhibition.

J Wouters1.   

Abstract

Among the various types of amine oxidases, monoamine oxidase (MAO) is of special interest for neuropsychiatry. It appears to play a central role in several psychiatric and neurological disorders, including clinical depression and Parkinson's Disease. The purpose of this paper is to review the major structural aspects of MAO, in relation with its primary sequence (site-directed mutagenesis, chimeric constructions), secondary and three-dimensional structures. The consequences of the inhibition of monoamine oxidase are considered, mainly focusing on the new generations of reversible and selective MAO inhibitors. Recent efforts to design and develop those inhibitors are emphasized and discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9481038

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  26 in total

1.  Charge-transfer interactions in the inhibition of MAO-A by phenylisopropylamines--a QSAR study.

Authors:  Gabriel Vallejos; Marcos Caroli Rezende; Bruce K Cassels
Journal:  J Comput Aided Mol Des       Date:  2002-02       Impact factor: 3.686

2.  Synthesis and evaluation of small molecules bearing a benzyloxy substituent as novel and potent monoamine oxidase inhibitors.

Authors:  Jin-Shuai Lan; Tong Zhang; Yun Liu; Yong Zhang; Jian-Wei Hou; Sai-Sai Xie; Jing Yang; Yue Ding; Zhen-Zhen Cai
Journal:  Medchemcomm       Date:  2017-01-05       Impact factor: 3.597

Review 3.  Predicting monoamine oxidase inhibitory activity through ligand-based models.

Authors:  Santiago Vilar; Giulio Ferino; Elias Quezada; Lourdes Santana; Carol Friedman
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

4.  Regulation of monoamine oxidase A (MAO-A) expression, activity, and function in IL-13-stimulated monocytes and A549 lung carcinoma cells.

Authors:  Sukhamoy Dhabal; Pradip Das; Pritam Biswas; Priyanka Kumari; Valentin P Yakubenko; Suman Kundu; Martha K Cathcart; Manjari Kundu; Kaushik Biswas; Ashish Bhattacharjee
Journal:  J Biol Chem       Date:  2018-07-18       Impact factor: 5.157

5.  Serotonin produces monoamine oxidase-dependent oxidative stress in human heart valves.

Authors:  Ricardo A Peña-Silva; Jordan D Miller; Yi Chu; Donald D Heistad
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-08-07       Impact factor: 4.733

6.  Monoamine oxidase A (MAO-A): a signature marker of alternatively activated monocytes/macrophages.

Authors:  Martha K Cathcart; Ashish Bhattacharjee
Journal:  Inflamm Cell Signal       Date:  2014

7.  An in vitro interethnic comparison of monoamine oxidase activities between Japanese and Caucasian livers using rizatriptan, a serotonin receptor 1B/1D agonist, as a model drug.

Authors:  T Iwasa; H Sano; A Sugiura; N Uchiyama; K Hara; H Okochi; K Nakagawa; T Yasumori; T Ishizaki
Journal:  Br J Clin Pharmacol       Date:  2003-11       Impact factor: 4.335

8.  In vivo quantification of monoamine oxidase A in baboon brain: a PET study using [(11)C]befloxatone and the multi-injection approach.

Authors:  Michel Bottlaender; Héric Valette; Jacques Delforge; Wadad Saba; Ilonka Guenther; Olivier Curet; Pascal George; Frédéric Dollé; Marie-Claude Grégoire
Journal:  J Cereb Blood Flow Metab       Date:  2009-11-18       Impact factor: 6.200

9.  Metabolism of 2-phenylethylamine and phenylacetaldehyde by precision-cut guinea pig fresh liver slices.

Authors:  Georgios I Panoutsopoulos; Demetrios Kouretas; Elias G Gounaris; Christine Beedham
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2004 Apr-Jun       Impact factor: 2.441

10.  Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction.

Authors:  R R Ramsay; C Dunford; P K Gillman
Journal:  Br J Pharmacol       Date:  2007-08-27       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.